Chemosaturation of the Liver - an Update. / Chemosaturation der Leber ein Update.
Rofo
; 195(1): 30-37, 2023 01.
Article
em En, De
| MEDLINE
| ID: mdl-35977553
ABSTRACT
BACKGROUND:
Percutaneous hepatic perfusion (CS-PHP) is a treatment option for primary and secondary liver neoplasms and subject of intensive research. This present article provides an overview of CS-PHP regarding patient safety, feasibility and effectiveness based on recent studies.METHOD:
We performed a PubMed search including the search terms chemosaturation, hepatic chemosaturation, percutaneous perfusion and melphalan. RESULTS ANDCONCLUSION:
CS-PHP is a promising procedure for the treatment of uveal melanoma and cholangiocellular carcinoma. There are insufficient data regarding the effectiveness of CS-PHP with respect to other tumor entities. Since CS-PHP can be accompanied by multiple transient side effects and complications, close interdisciplinary cooperation is necessary. KEY POINTS · Chemosaturation of the liver is a safe procedure.. · CS-PHP is a potent therapy for hepatic metastatic ocular melanoma and cholangiocellular carcinoma.. · The procedure requires close interdisciplinary coordination.. · CS-PHP is a repeatable and thus long-term therapeutic option for some patients.. CITATION FORMAT · Ebel S, Struck MF, van Boemmel F etâal. Chemosaturation of the Liver - an Update. Fortschr Röntgenstr 2023; 195 30â-â37.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Colangiocarcinoma
/
Neoplasias Hepáticas
Limite:
Humans
Idioma:
De
/
En
Ano de publicação:
2023
Tipo de documento:
Article